Viewing Study NCT02305134


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2026-02-27 @ 8:31 PM
Study NCT ID: NCT02305134
Status: COMPLETED
Last Update Posted: 2019-03-19
First Post: 2014-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial
Sponsor: Chiba University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Attention Deficit Disorder With Hyperactivity Disease View
None Hyperkinesis View
None Attention Deficit and Disruptive Behavior Disorders View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tipepidine, GIRK View